Michael Howell
Co-Founder Galileo Biosystems
Seminars
Wednesday 4th November 2026
From Ocean Biology to Dermatology Therapeutics: Using Translational Science to Identify Biomarkers, Validate Targets & Accelerate Drug Discovery
2:00 pm
- Applying translational medicine approaches to uncover novel biomarkers and therapeutic pathways, transforming biological observations into validated targets for inflammatory skin disease
- Exploring how mechanistic insights into oxidative stress, immune regulation and tissue homeostasis can strengthen target selection, increasing confidence in emerging pathways such as AHR before clinical development
- Sharing lessons from translating novel biological discoveries into dermatology drug candidates, demonstrating how early biomarker characterization can reduce development risk and improve the probability of clinical success
